Amit Sachdev - Feb 10, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Patient Officer
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 10, 2022
Transactions value $
-$592,210
Form type
4
Date filed
2/14/2022, 03:20 PM
Previous filing
Feb 3, 2022
Next filing
Feb 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$592K -2.49K -4.05% $237.74 59.1K Feb 10, 2022 Direct
holding VRTX Common Stock 882 Feb 10, 2022 401(k)
holding VRTX Common Stock 15.6K Feb 10, 2022 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.